Barclays
MDXG icon

Barclays’s MiMedx Group MDXG Stock Holding History

Barclays’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-194,300
Closed -$1.2M – 7161
2018
Q3 		$1.2M Sell
194,300
-237,400
-55% -$1.07M ﹤0.01% 3459
2018
Q2 		$2.76M Buy
431,700
+162,300
+60% +$1.16M ﹤0.01% 2269
2018
Q1 		$1.88M Buy
269,400
+240,200
+823% +$2.8M ﹤0.01% 2522
2017
Q4 		$368K Buy
29,200
+10,400
+55% +$127K ﹤0.01% 4145
2017
Q3 		$223K Buy
+18,800
New +$279K ﹤0.01% 4333

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Barclays's MDXG Position: Q1 2026 in Review

Barclays reduced its MiMedx Group (MDXG) stake by 50% in Q1 2026, selling an estimated $948K and leaving 187,459 shares worth $740K. The position accounts for ﹤0.01% of the portfolio, ranked #2937.

Barclays first reported a position in MDXG in Q2 2013 and has held it in 36 quarters since. The position peaked at $9.38M in Q3 2017. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Barclays held 187,459 shares of MiMedx Group worth $740K as of Q1 2026.
  • Barclays sold 188,166 MiMedx Group shares in Q1 2026, an estimated $948K.
  • MiMedx Group made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2937 holding.
  • Barclays first reported a position in MiMedx Group in Q2 2013 and has held it in 36 quarters since.
  • Barclays's MiMedx Group position peaked at $9.38M in Q3 2017.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.